arrow

From NeuroLex

Jump to: navigation, search



Resource:CATIE - Clinical Antipsychotic Trials in Intervention Effectiveness

Name: Resource:CATIE - Clinical Antipsychotic Trials in Intervention Effectiveness
Description: The NIMH-funded Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Study was a nationwide public health-focused clinical trial that compared the effectiveness of older (first available in the 1950s) and newer (available since the 1990s) antipsychotic medications used to treat schizophrenia.

These newer medications, known as atypical antipsychotics, cost roughly 10 times as much as the older medications. CATIE is the largest, longest, and most comprehensive independent trial ever done to examine existing therapies for this disease. Schizophrenia is a brain disorder characterized by hallucinations, delusions, and disordered thinking. The course of schizophrenia is variable, but usually is recurrent and chronic, often causing severe disability. Previous studies have shown that taking antipsychotic medications consistently is far more effective than taking no medicine and that the drugs are necessary to manage the disease. The aim of the CATIE study was to determine which medications provide the best treatment for schizophrenia.

Additional information may be found by following the links, http://www.nimh.nih.gov/trials/practical/catie/index.shtml, http://www.clinicaltrials.gov/ct/show/NCT00014001?order=1
Other Name(s): Clinical Antipsychotic Trials in Intervention Effectiveness, CATIE Schizophrenia Study, Clinical Antipsychotic Trials in Intervention Effectiveness - Schizophrenia
Abbreviation: CATIE, CATIE Schizophrenia
Parent Organization: University of North Carolina at Chapel Hill; North Carolina; USA
Supporting Agency: National Institute of Mental Health
Resource Type(s): Clinical trial
Resource: Resource
URL: http://www.catie.unc.edu/schizophrenia/index.html
*Id: nlx_146233
Related condition/disease: Schizophrenia
Related to: Resource:Clinicaltrials.gov: A Service Of The National Institutes Of Health
Keywords: Schizophrenia, Clinical trial, Treatment, Outcome, Antipsychotic
Organism: Human
Link to OWL / RDF: Download this content as OWL/RDF

Categories related to Resource:CATIE - Clinical Antipsychotic Trials in Intervention Effectiveness

Resource:CATIE - Alzheimers Disease, Resource:Limited Access Datasets From NIMH Clinical Trials, Resource:NIMH Center for Collaborative Genetic Studies on Mental Disorders

Curation status: Uncurated

This resource will be curated within 7 days.

For Resource Owners:
After the resource is curated, you may create a sitemap, which will help keep your registry description up-to-date and inform search engines about your resource.

Note: For a new resource, the website's URL must first be verified by a NIF curator before you may proceed.

Learn more about what NIF can do for your resource.
Proudly proclaim your inclusion in NIF by displaying the "Registered with NIF" button on your site. Please login to create the sitemap. (top right)

Notes

This page uses this default form:Resource



bookmark

*Note: Neurolex imports many terms and their ids from existing community ontologies, e.g., the Gene Ontology. Neurolex, however, is a dynamic site and any content beyond the identifier should not be presumed to reflect the content or views of the source ontology. Users should consult with the authoritative source for each ontology for current information.

Facts about Resource:CATIE - Clinical Antipsychotic Trials in Intervention EffectivenessRDF feed
AbbrevCATIE, CATIE Schizophrenia  +
AltURLhttp://www.nimh.nih.gov/health/trials/practical/catie/phase1results.shtml  +
CurationStatuscurated  +
DefiningCitationhttp://www.nimh.nih.gov/health/trials/practical/catie/index.shtml  +
DefinitionThe NIMH-funded Clinical Antipsychotic Tri The NIMH-funded Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Study was a nationwide public health-focused clinical trial that compared the effectiveness of older (first available in the 1950s) and newer (available since the 1990s) antipsychotic medications used to treat schizophrenia.

These newer medications, known as atypical antipsychotics, cost roughly 10 times as much as the older medications. CATIE is the largest, longest, and most comprehensive independent trial ever done to examine existing therapies for this disease. Schizophrenia is a brain disorder characterized by hallucinations, delusions, and disordered thinking. The course of schizophrenia is variable, but usually is recurrent and chronic, often causing severe disability. Previous studies have shown that taking antipsychotic medications consistently is far more effective than taking no medicine and that the drugs are necessary to manage the disease. The aim of the CATIE study was to determine which medications provide the best treatment for schizophrenia.

Additional information may be found by following the links, http://www.nimh.nih.gov/trials/practical/catie/index.shtml, http://www.clinicaltrials.gov/ct/show/NCT00014001?order=1
icaltrials.gov/ct/show/NCT00014001?order=1
ExampleImageCATIE.PNG  +
Has default formThis property is a special property in this wiki.Resource  +
Has roleClinical trial  +
Idnlx_146233  +
Is part ofUniversity of North Carolina at Chapel Hill; North Carolina; USA  +
KeywordsSchizophrenia  +, Clinical trial  +, Treatment  +, Outcome  +, and Antipsychotic  +
LabelResource:CATIE - Clinical Antipsychotic Trials in Intervention Effectiveness  +
ModifiedDate26 July 2014  +
OldURLhttp://www.catie.unc.edu/schizophrenia/index.html  +
Page has default formThis property is a special property in this wiki.Resource  +
RelatedToResource:Clinicaltrials.gov: A Service Of The National Institutes Of Health  +
Related diseaseSchizophrenia  +
SpeciesHuman  +
SuperCategoryResource  +
Supporting AgencyNational Institute of Mental Health  +
SynonymClinical Antipsychotic Trials in Intervention Effectiveness  +, CATIE Schizophrenia Study  +, and Clinical Antipsychotic Trials in Intervention Effectiveness - Schizophrenia  +